Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish

Circulation Research

Volumn 104, Issue 8, 2009, Pages 952-960

  Stoletov, Konstantin ^a   Fang, Longhou ^a   Choi, Soo Ho ^a   Hartvigsen, Karsten ^a   Hansen, Lotte F ^a   Hall, Chris ^b   Pattison, Jennifer ^a   Juliano, Joseph ^a   Miller, Elizabeth R ^a   Almazan, Felicidad ^a   Crosier, Phil ^b   Witztum, Joseph L ^a   Klemke, Richard L ^a   Miller, Yury I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Atherosclerosis; Macrophage; Oxidized lipoprotein; Zebrafish

Indexed keywords

CHOLESTEROL ESTER; DEXTRAN; EZETIMIBE; GREEN FLUORESCENT PROTEIN; LIPOPROTEIN; PHOSPHOLIPASE A2; RED FLUORESCENT PROTEIN; TOLL LIKE RECEPTOR 4; AZETIDINE DERIVATIVE; ENHANCED GREEN FLUORESCENT PROTEIN; FLUORESCENT PROTEIN 583; HYPOCHOLESTEROLEMIC AGENT; PHOTOPROTEIN; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BLOOD VESSEL WALL; CELL ADHESION; CELL AGGREGATION; CHOLESTEROL DIET; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; FLUORESCENCE ANALYSIS; GRANULOCYTE; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; LARVA; LIPID STORAGE; LIPID TRANSPORT; MACROPHAGE; MALE; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; ZEBRA FISH; AGE; AGING; ANIMAL; ATHEROSCLEROSIS; BLOOD; CELL LINE; CHOLESTEROL INTAKE; DISEASE MODEL; DRUG EFFECT; GENETICS; HUMAN; LIPID METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PERMEABILITY; PRENATAL DEVELOPMENT; TIME; TRANSGENIC ANIMAL; TRANSPLANTATION; VASCULAR ENDOTHELIUM;

AGE FACTORS; AGING; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; AZETIDINES; CELL LINE; CHOLESTEROL, DIETARY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; HYPERCHOLESTEROLEMIA; LARVA; LIPID METABOLISM; LIPOPROTEINS; LUMINESCENT PROTEINS; MACROPHAGES; MALE; MICE; MICROSCOPY, CONFOCAL; OXIDATION-REDUCTION; PERMEABILITY; PHOSPHOLIPASES A2; TIME FACTORS; TOLL-LIKE RECEPTOR 4; ZEBRAFISH;

EID: 65449167555     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.189803     Document Type: Article

References (34)

1. Lawson ND, Weinstein BM. In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol. 2002;248:307-318.
2. Stoletov K, Montel V, Lester RD, Gonias SL, Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci U S A. 2007;104:17406-17411.
3. Babin PJ, Vernier JM. Plasma lipoproteins in fish. J Lipid Res. 1989;30: 467-489.
4. Vastesaeger MM, Delcourt R. The natural history of atherosclerosis. Circulation. 1962;26:841-855.
5. Seierstad SL, Poppe TT, Koppang EO, Svindland A, Rosenlund G, Froyland L, Larsen S. Influence of dietary lipid composition on cardiac pathology in farmed Atlantic salmon, Salmo salar L. J Fish Dis. 2005; 28:677-690.
6. Poupard G, Andre M, Durliat M, Ballagny C, Boeuf G, Babin PJ. Apolipoprotein E gene expression correlates with endogenous lipid nutrition and yolk syncytial layer lipoprotein synthesis during fish development. Cell Tissue Res. 2000;300:251-261.
7. Durliat M, Andre M, Babin PJ. Conserved protein motifs and structural organization of a fish gene homologous to mammalian apolipoprotein E. Eur J Biochem. 2000;267:549-559.
8. Marza E, Barthe C, Andre M, Villeneuve L, Helou C, Babin PJ. Developmental expression and nutritional regulation of a zebrafish gene homologous to mammalian microsomal triglyceride transfer protein large subunit. Dev Dyn. 2005;232:506-518.
9. Schlegel A, Stainier DYR. Microsomal triglyceride transfer protein is required for yolk lipid utilization and absorption of dietary lipids in zebrafish larvae. Biochemistry. 2006;45:15179-15187.
10. Babin PJ, Thisse C, Durliat M, Andre M, Akimenko MA, Thisse B. Both apolipoprotein E and A-I genes are present in a nonmammalian vertebrate and are highly expressed during embryonic development. Proc Natl Acad Sci U S A. 1997;94:8622-8627.
11. Farber SA, Olson ES, Clark JD, Halpern ME. Characterization of Ca2 -dependent phospholipase A2 activity during zebrafish embryogenesis. J Biol Chem. 1999;274:19338-19346.
12. Rawls JF, Samuel BS, Gordon JI. From The cover: gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota. Proc Natl Acad Sci U S A. 2004;101:4596-4601.
13. Smart EJ, De Rose RA, Farber SA. Annexin 2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport. Proc Natl Acad Sci U S A. 2004;101:3450-3455.
14. Ho SY, Lorent K, Pack M, Farber SA. Zebrafish fat-free is required for intestinal lipid absorption and Golgi apparatus structure. Cell Metab. 2006;3:289-300.
15. Froystad MK, Volden V, Berg T, Gjoen T. Metabolism of oxidized and chemically modified low density lipoproteins in rainbow trout-clearance via scavenger receptors. Dev Comp Immunol. 2002;26:723-733.
16. Kaur H, Jaso-Friedmann L, Evans DL. Identification of a scavenger receptor homologue on nonspecific cytotoxic cells and evidence for binding to oligodeoxyguanosine. Fish Shellfish Immunol. 2003;15: 169-181.
17. Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med. 2005;353:46-57.
18. Hartvigsen K, Binder CJ, Hansen LF, Rafia A, Juliano J, Horkko S, Steinberg D, Palinski W, Witztum JL, Li AC. A Diet-induced hypercho-lesterolemic murine model to study atherogenesis without obesity and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2007;27:878-885.
19. Khouw AS, Parthasarathy S, Witztum JL. Radioiodination of low density lipoprotein initiates lipid peroxidation: protection by use of antioxidants. J Lipid Res. 1993;34:1483-1496.
20. Glass CK, Witztum JL. Atherosclerosis. The road ahead. Cell. 2001;104: 503-516.
21. Hall C, Flores MV, Storm T, Crosier K, Crosier P. The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish. BMC Dev Biol. 2007;7:42.
22. Mullick AE, Soldau K, Kiosses WB, Bell TA III, Tobias PS, Curtiss LK. Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med. 2008;205:373-383.
23. Farber SA, Pack M, Ho SY, Johnson ID, Wagner DS, Dosch R, Mullins MC, Hendrickson HS, Hendrickson EK, Halpern ME. Genetic analysis of digestive physiology using fluorescent phospholipid reporters. Science. 2001;292:1385-1388.
24. Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN, Witztum JL. Minimally modified LDL binds to CD14, induces macro-phage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem. 2003;278:1561-1568.
25. Miller YI, Viriyakosol S, Worrall DS, Boullier A, Butler S, Witztum JL. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol. 2005;25:1213-1219.
26. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/ 10ScCr mice: mutations in Tlr4 Gene. Science. 1998;282:2085-2088.
27. Steinberg D, Glass CK, Witztum JL. Evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Circulation. 2008; 118:672-677.
28. Martinez-Alvarez R, Morales A, Sanz A. Antioxidant defenses in fish: biotic and abiotic factors. Rev Fish Biol Fish. 2005;15:75-88.
29. Kiechl S, Willeit J, Mayr M, Viehweider B, Oberhollenzer M, Kronenberg F, Wiedermann CJ, Oberthaler S, Xu Q, Witztum JL, Tsimikas S. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol. 2007;27:1788-1795.
30. Bjorkbacka H, Kunjathoor VV, Moore KJ, Koehn S, Ordija CM, Lee MA, Means T, Halmen K, Luster AD, Golenbock DT, Freeman MW. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med. 2004;10:416-421.
31. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A. 2004;101:10679-10684.
32. Miller YI, Worrall DS, Funk CD, Feramisco JR, Witztum JL. Actin polymerization in macrophages in response to oxidized LDL and apo-ptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase. Mol Biol Cell. 2003;14:4196-4206.
33. Harkewicz R, Hartvigsen K, Almazan F, Dennis EA, Witztum JL, Miller YI. Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized LDL. J Biol Chem. 2008;283:10241-10251.
34. Kidd KR, Weinstein BM. Fishing for novel angiogenic therapies. Br J Pharmacol. 2003;140:585-594.